Most orders ship within 1 business day. Shipping times for:
* Excludes Alaska and Hawaii
Even big or heavy items, nebulizers and oxygen supplies, ship free. If your order
total is $75+, the shipping's on us!
Omron Micro-Air Electronic Nebulizer System NE-U22V1
PARI LC Sprint Reusable Nebulizer Set
Medquip Penguin Nebulizer System
Handi-Air Tote Wheeled Oxygen Carrier
Respironics EasyLife Nasal CPAP Mask - no longer selling
Health-Ox Fingertip Pulse Oximeter
Approximately 70,000 people live with Cystic Fibrosis, a hereditary respiratory disorder caused by faulty genes. That number is growing; an estimated 1,000 new cases of CF are documented each year.
Fortunately, scientists around the world are working on a new treatment called gene therapy. In this therapy, “copies of a normal gene are inserted into the DNA of cells to counter the effects of the faulty gene.”
16 year old Mary Bondonno participated in one of the recent clinical trials. Due to cystic fibrosis, Mary has to undergo an extensive hour long treatment every morning just to manage her symptoms. The treatment includes breathing exercises, nebulizers, inhalers, and physiotherapy. But once Mary started receiving gene therapy, she found it made a huge difference, “I had a lot more energy, I didn’t need my wheelchair, my grades were going up, and I was getting a lot more done,” she said.
Unfortunately, once the trail stopped, so did her gene therapy. “It was the best year of my life. So I want that back.”
Currently, scientists are looking for ways to amplify and enhance gene therapy, as well as trying to make the treatment more available. One new strategy for enhancement is called cationic liposome. In this strategy, DNA is delivered to the faulty gene via a fatty container which delivers DNA directly to a cell. Initial results “show promise.”
Hopefully, we will soon live in a world where cystic fibrosis is more manageable thanks to gene therapy.
* Required Fields